Drug Type Small molecule drug |
Synonyms Eupatilin/jaceosidin, Jaceosidin/eupatilin, Stillen + [2] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (29 Apr 2005), |
Regulation- |
Molecular FormulaC18H16O7 |
InChIKeyDRRWBCNQOKKKOL-UHFFFAOYSA-N |
CAS Registry22368-21-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Gastritis | South Korea | 29 Apr 2005 | |
Stomach Ulcer | South Korea | 29 Apr 2005 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anaphylaxis | Discovery | South Korea | 20 Mar 2005 | |
Anaphylaxis | Discovery | South Korea | 20 Mar 2005 |
Not Applicable | - | hetvmzjbyh(znklwkqstd) = tpbggcncwm faakxdcqpo (cuvmyqfmzf ) | - | 09 Oct 2022 | |||
hetvmzjbyh(znklwkqstd) = zmlkuccext faakxdcqpo (cuvmyqfmzf ) | |||||||
Not Applicable | - | (vffydchsnu) = xsphsohxrv qnvbvpwvvm (ukrqxlrzaf ) | - | 01 Oct 2019 | |||
Pantoprazole 40mg + Placebo | (vffydchsnu) = xiygukkkwn qnvbvpwvvm (ukrqxlrzaf ) | ||||||
Phase 3 | 434 | egkdzzqaoz(rnhlhwccum) = AEs were reported in 18 (8.4%) patients in the DA-5204 group and 19 (8.8%) in the DA-9601 group uexfqbxwoc (emireyztis ) | Positive | 01 Nov 2017 | |||